15 December 2002
Morphological Assessment of Reperfusion Injury in a Concordant Xenogeneic Primate Model
A Beiras-Fernandez, E Thein, D Chappell, C HammerAnn Transplant 2003; 8(3): 50-52 :: ID: 7531
Abstract
Ischemia and consecutive reperfusion injury of the graft cannot be avoided in organ transplantation. One principal characteristic of this process is the temporary and permanent adherence of leukocytes to endothelial cells of the graft as well as damage of the associated tissue. Polyclonal antithymocyte globulins (ATGs) are used to prevent acute rejection after transplantation and to overcome graft vs. host disease. ATGs induce apoptosis and complement-mediated cell death in peripheral T-lymphocytes having the potential to inhibit leukocyte adhesion by direct binding to adhesion molecules. The aim of the present study was to analyse in a non-human primate model (cynomolgus monkeys) morphological changes within the microvasculature and the different cell-subpopulations upon ischemia/reperfusion after immunosuppressive treatment. Our results show a decrease of the tissue damage and WBC infiltration in muscular structures as well as a lower number of mononuclear cells in peripheral blood in the ATG-treated group compared to a non-treated control group. We may conclude that pATGs have a beneficial effect on the early mechanisms of ischemia/reperfusion injury.
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






